BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Art Pappas will speak at the Drug Repositioning Summit on October 6 in Boston, MA
News | 10. 06. 2008
